NCT06852638RecruitingPhase 2
CD70-targeted immunoPET Imaging of Malignant Cancers
CD70-targeted PET/ CT in the Diagnosis of Malignant Cancers
Source: ClinicalTrials.gov · Last updated 12 May 2026
Brief summary (registry, in English)
This study aims to determine the value of cluster of differentiation (CD70)-targeted immuno-positron emission tomography/computed tomography (immunoPET/CT) imaging for diagnosing human malignancies, including renal cell carcinoma (particularly clear cell renal cell carcinoma), lymphoma, and nasopharyngeal carcinoma (NPC), among others.
- Status (registry)
- Recruiting
- Phase (registry)
- Phase 2
- Study type
- Interventional
- Enrollment
- 300 (estimated)
- First submitted
- 16 Feb 2025
- Start date
- 23 Dec 2024
- Primary completion date
- 23 Dec 2026
- Lead sponsor
- RenJi Hospital
- NCT number
- NCT06852638
What you commit to
- Study type: Interventional · Phase 2
- Planned participants: 300
- From 23 Dec 2024 to the primary completion date, 23 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Severe hepatic and renal insufficiency;
- Allergic to single-domain antibody radiopharmaceuticals.
Other
- Pregnancy；
Who the study is looking for
- Aged 18-80 year-old and of either sex；
- Histologically confirmed diagnosis of renal cancer (especially ccRCC)/lymphoma/NPC or suspected renal cancer/lymphoma/NPC by diagnostic imaging;
- Capable of giving signed informed consent, including compliance with the requirements and restrictions in the informed consent form (ICF) and this protocol.
Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Renji Hospital, School of Medicine, Shanghai Jiao Tong University Coordinator of this site? Confirm its status | Shanghai | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.